Objectives: The aim of this study was to determine the frequency of venous
thromboembolism in critically ill coronavirus disease 2019 patients and associate a degree …

Objectives: One of the defining features of the novel coronavirus disease 2019 infection has
been high rates of venous thromboses. The present study aimed to describe the prevalence …

Objectives: Recent studies have reported a high prevalence of thrombotic events in
coronavirus disease 2019. However, the significance of thromboembolic complications has …

Objectives: To assess the role of thromboprophylaxis regimens on the occurrence of
pulmonary embolism in coronavirus disease 2019 patients. Design: Retrospective analysis …

OBJECTIVES: Severe coronavirus disease 2019 is associated with an extensive
pneumonitis and frequent coagulopathy. We sought the true prevalence of thrombotic …

Objectives: The rate of thromboembolic events among patients with coronavirus disease
2019 is high; however, there is no robust method to identify those at greatest risk. We …

Background: Accumulating evidence suggests that coronavirus disease 2019 (COVID-19) is
associated with hypercoagulative status, particularly for critically ill patients in the intensive …

Objective Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus confers a risk of significant coagulopathy, with the resulting development of venous …

Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

Background We aimed to identify the prevalence and predictors of venous
thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) …